|
Neonatal Cholestasis: A Pandora's Box |
|
|
Outcomes of Pediatric Liver Transplantation: Deceased Donor Liver Transplantation vs Living Donor Liver Transplantation. |
|
|
The antioxidant effects of Hydroxytyrosol and Vitamin E on pediatric NAFLD, in a clinical trial: a new treatment? |
|
|
Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand? |
|
|
The effectiveness of oral antiviral (Sofosbuvir/Ledipasvir) in treating children with HCV infection. |
|
|
Fatigue in pediatric liver transplant recipients and its impact on their quality of life. |
|
|
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease. |
|
|
Mild to Moderate Intrapulmonary Shunting in Pediatric Liver Transplantation: Is Screening Necessary? |
|
|
Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (... |
|
|
Acute-on-chronic liver failure in children with biliary atresia awaiting liver transplantation. |
|
|
Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children |
|
|
Clinical features of children with Epstein-Barr virus-related acute liver failure: an analysis of four cases |
|
